Breaking the connection between cutaneous IL-13 and IL-13Rα2 as well as TLR2 and IL-13Rα2 will block the excessive release of these cytokines and hypersensitization of AD, and therefore attenuate itching conditions [149]. Here, IL13 is linked to Alzheimer disease.